Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt Licenses Kinase Sequencing Assays from Dana-Farber

NEW YORK, May 13 (GenomeWeb News) - Agencourt Bioscience, of Beverly, Mass., has licensed pre-validated SNP sequencing assays for kinases from Dana-Farber Cancer Institute, the company said today.


Kinases are implicated in a variety of human diseases, particularly cancer. The sequencing assays, which were developed in the laboratories of Dana-Farber cancer researchers Matthew Meyerson and William Sellers, will be offered as part of Agencourt's SNP discovery service for kinases. The company said that the service will allow analysis of kinase SNPs for "over 92 genes."


Financial terms of the agreement were not disclosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.